statistiche ricercatore

Nazione	#
US - Stati Uniti d'America	519
IT - Italia	196
SG - Singapore	163
CN - Cina	86
VN - Vietnam	65
BR - Brasile	56
BD - Bangladesh	37
DE - Germania	32
KR - Corea	31
FR - Francia	30
HK - Hong Kong	30
IN - India	30
SE - Svezia	24
NL - Olanda	23
FI - Finlandia	13
MA - Marocco	13
PL - Polonia	13
TR - Turchia	13
IE - Irlanda	10
AR - Argentina	9
RO - Romania	9
RU - Federazione Russa	9
AU - Australia	8
CA - Canada	8
GB - Regno Unito	8
MX - Messico	8
ZA - Sudafrica	8
AT - Austria	7
JP - Giappone	7
ID - Indonesia	5
IR - Iran	5
PH - Filippine	5
EC - Ecuador	4
EG - Egitto	4
IQ - Iraq	4
BE - Belgio	3
ES - Italia	3
JO - Giordania	3
PK - Pakistan	3
BG - Bulgaria	2
BO - Bolivia	2
CH - Svizzera	2
CL - Cile	2
CO - Colombia	2
DZ - Algeria	2
GR - Grecia	2
LB - Libano	2
SA - Arabia Saudita	2
SK - Slovacchia (Repubblica Slovacca)	2
TW - Taiwan	2
UZ - Uzbekistan	2
AE - Emirati Arabi Uniti	1
BB - Barbados	1
CZ - Repubblica Ceca	1
DK - Danimarca	1
DO - Repubblica Dominicana	1
GE - Georgia	1
IL - Israele	1
KG - Kirghizistan	1
LK - Sri Lanka	1
LT - Lituania	1
LV - Lettonia	1
MD - Moldavia	1
MY - Malesia	1
NI - Nicaragua	1
NP - Nepal	1
OM - Oman	1
PE - Perù	1
PT - Portogallo	1
SI - Slovenia	1
UA - Ucraina	1
VE - Venezuela	1
Totale	1.549

Nome	#
Glypican 1-targeted therapeutic approaches adopting doxorubicin-loaded chitosan nanobubbles and antibody-based strategy in the context of Pancreatic Ductal Adenocarcinoma	353
A novel complement-fixing IgM antibody targeting GPC1 as a useful immunotherapeutic strategy for the treatment of pancreatic ductal adenocarcinoma	167
A novel epigenetic machine learning model to define risk of progression for hepatocellular carcinoma patients	167
New insight into therapies targeting angiogenesis in hepatocellular carcinoma	157
Glucose Metabolism and Oxidative Stress in Hepatocellular Carcinoma: Role and Possible Implications in Novel Therapeutic Strategies	153
The anti-glypican 1 AT101 antibody as targeting agent to effectively deliver chitosan nanobubbles to glioblastoma cells.	144
Idarubicin-loaded chitosan nanobubbles to improve survival and decrease drug side effects in hepatocellular carcinoma	140
The Proteoglycan Glypican-1 as a Possible Candidate for Innovative Targeted Therapeutic Strategies for Pancreatic Ductal Adenocarcinoma	113
Gut Microbiota-Based Immunotherapy: Engineered Escherichia coli Nissle 1917 for Oral Delivery of Glypican-1 in Pancreatic Cancer	95
Novel Nanotechnology Approaches to Overcome Drug Resistance in the Treatment of Hepatocellular Carcinoma: Glypican 3 as a Useful Target for Innovative Therapies	86
Targeted chitosan nanobubbles as a strategy to down-regulate microRNA-17 into B-cell lymphoma models	7
Totale	1.582

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2020/2021	11	0	0	0	0	0	0	0	0	0	0	0	11
2021/2022	43	3	0	3	0	0	0	0	1	1	1	1	33
2022/2023	115	4	12	5	13	18	18	0	16	17	4	3	5
2023/2024	98	17	6	5	4	4	10	17	18	1	6	10	0
2024/2025	377	9	10	11	41	19	36	27	31	37	47	56	53
2025/2026	938	113	38	134	104	75	50	109	31	100	91	74	19
Totale													1.582

ArTS Archivio della ricerca di Trieste